NCT04751292View on ClinicalTrials.gov

HIGH Altitude CArdiovascular REsearch Latin America Population Study

CompletedOBSERVATIONAL
Enrollment

937

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
HypertensionCardiovascular Risk FactorAltitude HypoxiaAltitude SicknessErythrocytosisSleep
Interventions
OTHER

Exposure to high altitude

permanence at high (\>2500 m) altitude; permanence is defined as being born and living at high altitude with the total time spent at lower altitudes not exceeding 2 years in the past 10 years

Trial Locations (1)

Unknown

Universidad Peruana Cayetano Heredia, Lima

All Listed Sponsors
collaborator

Universidad Peruana Cayetano Heredia

OTHER

collaborator

University of Milano Bicocca

OTHER

lead

Istituto Auxologico Italiano

OTHER

NCT04751292 - HIGH Altitude CArdiovascular REsearch Latin America Population Study | Biotech Hunter | Biotech Hunter